Compare OTH & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTH | ASRT |
|---|---|---|
| Founded | 2012 | 1995 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.8M | 76.0M |
| IPO Year | N/A | 2004 |
| Metric | OTH | ASRT |
|---|---|---|
| Price | $3.05 | $18.02 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 121.5K | ★ 216.9K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $118,713,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.61 |
| P/E Ratio | $600.18 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.70 | $0.57 |
| 52 Week High | $3.84 | $20.45 |
| Indicator | OTH | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 58.33 | 63.56 |
| Support Level | $3.01 | $0.70 |
| Resistance Level | $3.45 | $20.45 |
| Average True Range (ATR) | 0.41 | 1.19 |
| MACD | 0.13 | -0.18 |
| Stochastic Oscillator | 64.02 | 62.69 |
Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Dealerships and Financial Services. Dealerships segment consists of Specializing in the buying, selling, and wholesaling of yachts and boats. Having a boat dealership created to run Yellow Fin sales in Miami. Financial Services segment consists of a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages. The Dealerships segment generates maximum revenue. The services of the company includes: Sell Your Boat, Brokerage, Marine Financing, Get Pre-Qualified, Warranty & Extended Coverage, and Wholesale.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.